Search - tctmd.com

Displaying 101 - 120 of 1417

Sort: Relevancy | Date

Presentation TCT 2016

Opportunities and Risks of Data Sharing I: YODA Proposal

Presenter: C. Michael Gibson, A. Michael Lincoff, Harlan Krumholz

October 31, 2016

Presentation TCT 2016

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature

Presenter: Niall T. Mulvihill, Michael Mahmoudi

October 31, 2016

Presentation TCT 2016

The Moral Imperative and Potential Benefits of Data Sharing: Journalist Perspective

Presenter: C. Michael Gibson, A. Michael Lincoff, Eric D. Peterson

October 31, 2016

Presentation TCT 2016

Pragmatic Simple Trials and Big Data: Implications for NIH Funding

Presenter: Deepak L. Bhatt, Roxana Mehran, Michael S. Lauer

October 31, 2016

Presentation TCT 2016

MDIC and Industry Perspectives: Potential Effects of NEST on Research, Innovation and Patient Outcomes

Presenter: Owen Faris, Mitchell W. Krucoff, Michael R Minogue

October 31, 2016

Presentation TCT 2016

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo

October 31, 2016

Presentation TCT 2016

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry

Presenter: Michael J. Cowley, Franz-Josef Neumann, Joel Sainsous

October 31, 2016

Presentation TCT 2016

TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction: Procedural Success, Clinical Outcome, and Five-Year Follow-up

Presenter: Michael J. Cowley, Franz-Josef Neumann, Pablo Salinas

October 31, 2016

Presentation TCT 2016

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green

October 31, 2016

Presentation TCT 2016

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Blase A. Carabello

October 31, 2016

Presentation TCT 2016

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Presenter: Charles J. Davidson, Michael J. Reardon, James B. Hermiller Jr.

October 31, 2016

Presentation TCT 2016

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Daniel Burkhoff

October 31, 2016

Presentation TCT 2016

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Michael Haude

October 31, 2016

Title Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presentation TCT 2016

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron

October 31, 2016

Presentation TCT 2016

Rationale for and Design of GALILEO

Presenter: Michael Argenziano, Alec S. Vahanian, Paul Sorajja

October 31, 2016

Presentation TCT 2016

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Presenter: Charles J. Davidson, Michael J. Reardon, James Harvey

October 31, 2016

Presentation TCT 2016

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

Presentation TCT 2016

EVLA and RFA for Treatment of Lower Extremity Superficial Venous Disease

Presenter: Michael D. Dake, Michael R. Jaff, Sanjiv Lakhanpal

October 31, 2016

Presentation TCT 2016

Sclerotherapy and Non-Thermal Non-Tumescent Therapies for Treatment of Lower Extremity Superficial Venous Disease

Presenter: Michael D. Dake, Michael R. Jaff, Zvonimir Krajcer

October 31, 2016

Advertisement

Opportunities and Risks of Data Sharing I: YODA Proposal

TAVR for Intermediate-Risk and Low-Risk Patients: Review of the Literature

The Moral Imperative and Potential Benefits of Data Sharing: Journalist Perspective

Pragmatic Simple Trials and Big Data: Implications for NIH Funding

MDIC and Industry Perspectives: Potential Effects of NEST on Research, Innovation and Patient Outcomes

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry

TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction: Procedural Success, Clinical Outcome, and Five-Year Follow-up

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

TCT 30: Safety, Clinical Performance and Multi-Modality Imaging Data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with De Novo Lesions in Native Coronary Arteries at 12-Month Follow-Up-BIOSOLVE-II

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Rationale for and Design of GALILEO

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

EVLA and RFA for Treatment of Lower Extremity Superficial Venous Disease

Sclerotherapy and Non-Thermal Non-Tumescent Therapies for Treatment of Lower Extremity Superficial Venous Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content